SCHEMBL6060141

SCHEMBL6060141

CCCCc1ccc2cc(-c3ccc(-c4ccc(F)c(F)c4)c(F)c3)ccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 3/20 0.45
RARA P10276 1/20 0.42
RARG P13631 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
PSMB5 P28074 1/20 0.39
MPL P40238 3/20 0.38
AKR1C3 P42330 3/20 0.38
AKR1C2 P52895 3/20 0.38
HRH3 Q9Y5N1 2/20 0.37
CYP17A1 P05093 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
GCGR P47871 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36
SKP2 Q13309 1/20 0.36
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172288 0.96 RARB (0.50) RARBRARARARGESR1ESR2
SCHEMBL6059463 0.95 RARB (0.52) RARBRARARARGESR1ESR2
SCHEMBL3162651 0.95 RARB (0.52) RARBRARARARGESR1ESR2
SCHEMBL3159190 0.93 RARB (0.47) RARBRARARARGPSMB5HRH3
SCHEMBL3161005 0.92 ESR1 (0.44) RARBRARARARGESR1ESR2
SCHEMBL3163697 0.91 RARB (0.49) RARBRARARARGPSMB5HRH3
SCHEMBL14526078 0.90 RARB (0.50) RARBRARARARGPSMB5MPL
SCHEMBL17108400 0.90 RARB (0.50) RARBRARARARGPSMB5MPL
SCHEMBL3153476 0.89 RARB (0.46) RARBRARARARGESR1ESR2
SCHEMBL3167606 0.89 RARB (0.48) RARBRARARARGESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP claimed
US-10723951-B2 Naphthalene compounds for liquid-crystalline mixtures MERCK PATENT GMBH (DE) 2020-07-28 US disclosed
WO-2017097400-A1 NAPHTHALENE COMPOUNDS FOR LIQUID-CRYSTALLINE MIXTURES MERCK PATENT GMBH (DE) 2017-06-15 WO disclosed
US-7145047-B2 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-12-05 US disclosed
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP disclosed
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-07-24 US disclosed
EP-1273562-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed
US-6468607-B1 MISCIBILITY, LARGE BIREFRINGENCE INDEX, NO STRONGLY POLAR GROUP IN ITS MOLECULE AND THUS CAN ALSO BE USED FOR ACTIVE MATRIX DRIVING, WIDE TEMPERATURE RANGE AND REQUIRES A HIGH SPEED RESPONSE AND A LOW VOLTAGE DRIVING DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same NLK, NOTCH1, NOTCH4 RARB 4021/4885RARA 3552/4885RARG 3792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.